Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 25,758 shares at $60.15 ($1.5M) on 2021-07-28, disclosed to the SEC on 2021-07-28.
Open-market sale of $1.5M KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.15 | 9,015 | $542K | 35.0% |
| 2 | $60.15 | 9,015 | $542K | 35.0% |
| 3 | $60.15 | 3,864 | $232K | 15.0% |
| 4 | $60.15 | 3,864 | $232K | 15.0% |
| Total | $60.15 avg | 25,758 | $1.5M | 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2026-02-25 | $2.7M | — | Filing → |